Free tool
FAERS Monitor: Gattex Kit
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 203441 or its brand name (Gattex Kit, Teduglutide). Reports on generic versions are filed under their own applications.
Reports
13,437
Serious
11,269
84% of reports
Hospitalization
8,033
Death reported
1,153
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- weight decreased1,267
- vascular device infection1,178
- nausea1,106
- product dose omission issue1,074
- abdominal pain1,070
- diarrhoea1,061
- weight increased882
- dehydration876
- vomiting852
- death778
- abdominal distension726
- pyrexia632
- hospitalisation590
- inappropriate schedule of product administration546
- decreased appetite531
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 40 |
| 2014 | 273 |
| 2015 | 510 |
| 2016 | 370 |
| 2017 | 369 |
| 2018 | 1,131 |
| 2019 | 864 |
| 2020 | 1,130 |
| 2021 | 2,005 |
| 2022 | 2,075 |
| 2023 | 1,685 |
| 2024 | 1,305 |
| 2025 | 1,113 |
| 2026 | 565 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,722 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| vascular device infectionSignal | 1,178 | 548.5 | 514.4 | 476,471 |
| abdominal distensionSignal | 726 | 11.0 | 10.2 | 6,545 |
| dehydrationSignal | 876 | 10.3 | 9.7 | 7,381 |
| abdominal painSignal | 1,070 | 7.2 | 6.8 | 5,773 |
| weight decreasedSignal | 1,267 | 7.1 | 6.8 | 6,733 |
| weight increasedSignal | 882 | 6.2 | 5.8 | 3,855 |
| hospitalisationSignal | 590 | 6.0 | 5.6 | 2,479 |
| product dose omission issueSignal | 1,074 | 5.7 | 5.4 | 4,237 |
| inappropriate schedule of product administrationSignal | 546 | 4.8 | 4.4 | 1,624 |
| decreased appetiteSignal | 531 | 3.6 | 3.3 | 996 |
| pyrexiaSignal | 632 | 2.9 | 2.7 | 775 |
| vomitingSignal | 852 | 2.8 | 2.7 | 1,035 |
| diarrhoeaSignal | 1,061 | 2.6 | 2.4 | 1,052 |
| nauseaSignal | 1,106 | 2.2 | 2.1 | 740 |
| death | 778 | 1.4 | 1.3 | 98 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.